Novo Nordisk (NYSE:NVO) Q1 2026 Earnings call May 06, 2026 07:00 AM ET Company Participants Emil Kongshøj Larsen - EVP of International Operations Jamey Millar - EVP of US Operations Karsten Munk Knudsen - CFO Martin Holst Lange - EVP of Research and Development and Chief Scientific Officer Michael Novod - Head of Investor Relations Mike Doustdar - CEO Conference Call Participants Carsten Lønborg Madsen - Analyst Evan Seigerman - Analyst Florent Cespedes - Analyst Graham Parry - Analyst James Gordon - Analy ...